Source: Progress in neuro-psychopharmacology & biological psychiatry. Unidade: FM
Subjects: DEPRESSÃO, ANTIDEPRESSIVOS, INTERLEUCINAS, BIOMARCADORES
ABNT
BRUNONI, Andre R et al. Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression. Progress in neuro-psychopharmacology & biological psychiatry, v. 86, p. 211-217, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.pnpbp.2018.06.003. Acesso em: 14 out. 2024.APA
Brunoni, A. R., Padberg, F., Vieira, E. L. M., Teixeira, A. L., Carvalho, A. F., Lotufo, P. A., et al. (2018). Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression. Progress in neuro-psychopharmacology & biological psychiatry, 86, 211-217. doi:10.1016/j.pnpbp.2018.06.003NLM
Brunoni AR, Padberg F, Vieira ELM, Teixeira AL, Carvalho AF, Lotufo PA, Gattaz WF, Benseñor IJM. Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression [Internet]. Progress in neuro-psychopharmacology & biological psychiatry. 2018 ; 86 211-217.[citado 2024 out. 14 ] Available from: https://doi.org/10.1016/j.pnpbp.2018.06.003Vancouver
Brunoni AR, Padberg F, Vieira ELM, Teixeira AL, Carvalho AF, Lotufo PA, Gattaz WF, Benseñor IJM. Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression [Internet]. Progress in neuro-psychopharmacology & biological psychiatry. 2018 ; 86 211-217.[citado 2024 out. 14 ] Available from: https://doi.org/10.1016/j.pnpbp.2018.06.003